C1743812||Diacylglycerol Kinase ζ
C0079189||Cytokine
C0007595||Expansion
C0242629||CD8(+) T Cells
C0243095||Antitumor Capacity
C0021756||Interleukin-2
C0254610||-15
C0007595||expansion
C0007589||differentiation
C0039195||cytotoxic CD8(+) T cells
C0599733||antigen-independent killing
C0242629||T cell
C0087111||antitumor therapies
C3815868||Diacylglycerol kinase α
C1743812||ζ
C3815868||DGKα
C1743812||ζ
C1148560||metabolize
C0043791||diacylglycerol
C0242629||T lymphocytes
C1171362||expression
C0113519||lipid kinases
C0079722||tumor-infiltrating CD8(+) T cells
C0282683||tumor immune escape
C1524081||Inhibition
C0014442||enzymes
C0003320||antigen
C0027651||tumor
C3178995||elimination
C3815868||DGKα
C1743812||ζ
C0003320||antigen
C0242629||CD8(+) T cells
C0936012||Analysis
C1743812||DGKζ
C0025929||mice
C0949629||bystander memory
C0242629||CD8(+) T cell populations
C3815868||DGKα
C0025929||mice
C1743812||DGKζ
C2247677||cytokine responses
C0003320||antigen
C0079189||Cytokine
C0007595||expansion
C1743812||DGKζ
C0242629||CD8(+) T cells
C0007589||differentiation
C0039195||innate-like cytotoxic cells
C1515655||in vivo
C0243095||anti-tumor responses
C1743812||DGKζ
C0025929||mice
C0026809||murine A20
C0024299||lymphoma
C0597298||isoform
C1743812||DGKζ
C0522506||downstream
C0021756||IL-2
C0254610||IL-15
C0007595||expansion
C0039195||innate-like cytotoxic T cells
C0947647||manipulation
C1743812||DGKζ
C0243102||activity
C0079189||cytokine
C0087111||anti-tumor treatments